AdvocacyRSSApr 22
World Hemophilia Day on April 17 is highlighting the importance of getting diagnosed early and accurately for hemophilia and other bleeding disorders. Early diagnosis is being emphasized as a crucial first step that helps people with hemophilia manage their condition better and live healthier lives.
WHY IT MATTERSEarly and accurate diagnosis of hemophilia can significantly impact treatment outcomes and quality of life, making this awareness campaign directly relevant to patients seeking to optimize their care.
NewsRSSApr 22
This is a personal essay about someone's lifelong struggle with sleep, published on a hemophilia news website. The author describes how they've always found sleep difficult and treated it as optional, especially during high school. The article appears to be about learning better sleep habits, though the full content is cut off.
WHY IT MATTERSPeople with hemophilia often experience sleep disruption due to pain from joint bleeds and other complications, making sleep management strategies particularly relevant to this community.
ResearchRSSApr 22
Researchers developed an artificial intelligence tool that can accurately detect bleeding inside joints in adults with hemophilia by analyzing ultrasound images. This technology could eventually allow patients to get ultrasound scans at home instead of traveling to a hospital or clinic. Early detection of joint bleeding is important because it helps prevent long-term damage to the joints.
WHY IT MATTERSHemophilia patients currently must travel to medical facilities for ultrasound imaging to detect joint bleeds; this AI tool could enable home-based monitoring, reducing travel burden and potentially catching bleeding episodes earlier.
ResearchPUBMEDApr 22
Researchers in Germany studied health insurance records from 2017-2019 to understand how hemophilia A (a bleeding disorder) affects patients and how much it costs to treat. They found 257 patients with hemophilia A and grouped them by severity—mild, moderate, or severe—based on how much clotting medicine they needed. This study shows that insurance data can help doctors and researchers learn more about rare diseases like hemophilia A.
WHY IT MATTERSIf you have hemophilia A in Germany, this research demonstrates that your health insurance claims data can be used to better understand disease patterns, treatment costs, and care gaps—potentially leading to improved healthcare planning and resource allocation for your condition.
Clinical trialUNITERAREApr 3
This is a clinical trial testing a blood clotting medicine called Nuwiq in women and girls with hemophilia A who need surgery. Hemophilia A is a rare bleeding disorder where the body doesn't make enough of a protein that helps blood clot. The trial will study how well Nuwiq works and what dose is best for these patients during surgical procedures.
WHY IT MATTERSThis trial is specifically designed for women and girls with hemophilia A undergoing surgery — a population that often receives less research attention than males with the same condition.